Cardiovascular Repair And Reconstruction Devices Market Report 2026

Cardiovascular Repair And Reconstruction Devices Market Overview

• Cardiovascular Repair And Reconstruction Devices market size has reached to $6.1 billion in 2025 • Expected to grow to $9.45 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Growing Preference For Minimally Invasive Procedures Due To Patient Demand For Faster Recovery And Lower Procedural Risks • Market Trend: Technological Innovation In Next-Generation Surgical Aortic Tissue Valve Design Supporting Lifetime Patient Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiovascular Repair And Reconstruction Devices Market?

Cardiovascular repair and reconstruction devices refer to specialized medical instruments and implantable technologies used to restore, replace, or rebuild damaged or diseased structures of the heart and blood vessels, thereby improving blood flow, cardiac function, and overall circulatory health. These devices are commonly employed in surgical and minimally invasive procedures to treat conditions such as coronary artery disease, congenital heart defects, valvular disorders, aneurysms, and vascular trauma, enabling effective structural correction and long-term cardiovascular support. The main product types of cardiovascular repair and reconstruction devices include valve repair devices, vascular grafts, occluders, annuloplasty rings, and tissue patches. Valve repair devices refer to devices used to restore the function of damaged heart valves and improve blood flow. These devices are made from materials such as biological tissue, synthetic polymers, and metals and alloys. The applications include congenital heart defect closure, vascular reconstruction, cardiac structural repair, and other cardiovascular repair procedures, and the end users are hospitals, cardiac catheterization laboratories, ambulatory surgical centers, specialty clinics, and other end users.

What Is The Cardiovascular Repair And Reconstruction Devices Market Growth Forecast?

The cardiovascular repair and reconstruction devices market size is expected to see strong growth in the next few years. It will grow to $9.45 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac surgeries, expansion of aging population with vascular conditions, rising investments in advanced implant technologies, growth in personalized cardiovascular care, increasing adoption of hybrid surgical-interventional approaches. Major trends in the forecast period include increasing adoption of minimally invasive repair devices, rising use of bioprosthetic and hybrid implants, growing demand for customized Cardiovascular Implants, expansion of endovascular reconstruction techniques, enhanced focus on long-term device durability.

What Is The Driver Of The Cardiovascular Repair And Reconstruction Devices Market?

The growing preference for minimally invasive procedures is expected to propel the growth of the cardiovascular repair and reconstruction devices market going forward. Minimally invasive procedures are medical interventions performed through small incisions or natural openings that reduce tissue trauma, shorten recovery time, and lower procedural risk compared with traditional open surgery. The growing preference for minimally invasive procedures is increasing due to patients’ demand for faster recovery and lower procedural risks. Cardiovascular repair and reconstruction devices support this trend through widespread provision of coronary stents and delivery equipment central to PCI. For instance, in Jun 2024, according to the American Society of Plastic Surgeons, a US-based organization of board-certified plastic surgeons, minimally invasive procedures increased by 7% in 2023, exceeding the growth of traditional surgical procedures by 2%. Therefore, the growing preference for minimally invasive procedures is driving the growth of the cardiovascular repair and reconstruction devices industry.

Key Players In The Global Cardiovascular Repair And Reconstruction Devices Market

Major companies operating in the cardiovascular repair and reconstruction devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Stryker Corporation, Siemens Healthineers AG, Philips Healthcare, Becton Dickinson and Company, Boston Scientific Corporation, Baxter International Inc., Zimmer Biomet, Terumo Corporation, Getinge, Teleflex Incorporated, Cook Medical Inc, Merit Medical Systems, MicroPort Scientific Corporation, Shockwave, Artivion, Endologix Inc., LeMaitre Vascular Inc., W. L. Gore & Associates Inc., and Sorin Group.

Global Cardiovascular Repair And Reconstruction Devices Market Trends and Insights

Major companies operating in the cardiovascular repair and reconstruction devices market are focusing on developing advanced surgical bioprosthetic valve technologies, such as next-generation aortic tissue valves engineered for ease of implantation and future reintervention support. Next-generation aortic tissue valves are advanced bioprosthetic heart valves engineered using improved biomaterials and structural designs to replace diseased aortic valves during surgical or minimally invasive procedures, while enhancing implant ease, hemodynamic performance, durability, and compatibility with future valve-in-valve interventions. For instance, in April 2024, Medtronic plc, an Ireland–based medical technology company, launched the Avalus Ultra valve, incorporating a polyetheretherketone (PEEK) base frame for consistent circularity, a low valve profile for easier implant placement, and a radiopaque coil for clear visibility during future valve-in-valve procedures, facilitating streamlined lifetime patient management. It features a polyetheretherketone (PEEK) base frame, ensuring consistent circularity during implantation. It offers an industry-leading Effective Orifice Area (EOA), potentially enabling improved blood flow as supported by clinical evidence. Additionally, the valve includes a radiopaque coil, providing clear visibility to facilitate future valve-in-valve procedures.

What Are Latest Mergers And Acquisitions In The Cardiovascular Repair And Reconstruction Devices Market?

In February 2023, Abbott, a US-based provider of a broad portfolio of healthcare technologies including diagnostic systems, medical devices, and cardiovascular treatment solutions, acquired Cardiovascular Systems Inc. for an undisclosed amount. With this acquisition, Abbott aimed to expand and enhance its cardiovascular device portfolio by integrating CSI’s innovative atherectomy technologies to better address complex peripheral and coronary artery disease treatment needs. Cardiovascular Systems Inc. is US-based company that offers atherectomy systems (like the Diamondback 360 Orbital Atherectomy System) that are used to repair and reconstruct blood vessels by removing calcified and fibrous plaque from peripheral and coronary arteries.

What Defines the Cardiovascular Repair And Reconstruction Devices Market?

The cardiovascular repair and reconstruction devices market consists of sales of medical implants and instruments, vascular grafts, coronary stents, peripheral stents, heart valve prostheses, annuloplasty rings, vascular patches, and endovascular stent grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers of the devices, whether to other entities or directly to healthcare providers. The value of goods in this market includes related services offered by the manufacturers, such as device customization, training, and technical support.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiovascular Repair And Reconstruction Devices Market Report 2026?

The cardiovascular repair and reconstruction devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular repair and reconstruction devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.